AI assistant
Sending…
CME GROUP INC. — Director's Dealing 2016
Dec 13, 2016
29871_dirs_2016-12-13_01e0fcdb-4c1d-42d3-8afb-dec260c64e4a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CME GROUP INC. (CME)
CIK: 0001156375
Period of Report: 2016-12-12
Reporting Person: Pietrowicz John W. (Sr MD Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-12-12 | Common Stock Class A | M | 4625 | $110.54 | Acquired | 51794 | Direct |
| 2016-12-12 | Common Stock Class A | S | 4625 | $123.3032 | Disposed | 47169 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-12-12 | Non-Qualified Stock Option (right to buy) | $110.54 | M | 4625 | Disposed | 2017-06-15 | Common Stock Class A (4625) | Direct |
Footnotes
F1: On December 12, 2016, Mr. Pietrowicz sold an aggregate of 4,625 shares of CME Group Class A common stock. For reporting purposes, the sales prices within a $1 range have been aggregated and the weighted average sales price has been reported. The price ranges were: $123.30 to $123.33. The Company maintains a record of the transactions and copies will be provided upon request.
F2: On June 15, 2012, these options vested with respect to 100% of the granted number of shares covered by the option.
More from CME GROUP INC.
Proxy Solicitation & Information Statement
2026
May 19
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Interim / Quarterly Report
2026
Apr 24
Earnings Release
2026
Apr 22
Major Shareholding Notification
2026
Mar 26
Remuneration Information
2026
Mar 23
Annual Report
2026
Mar 23
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 19
Regulatory Filings
2026
Mar 17